Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

477
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
477
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

119
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
119
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.7K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

144
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
144
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

128
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
128
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

312
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
312

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes of COVID-19 in primary care: 5-Year follow-up of hospitalized and non-hospitalized patients in a population-based cohort study.

Semergen·2026
Same author

Evaluation, Management and Therapeutic Approach of Cardiovascular-Kidney-Metabolic Syndrome: A Multidisciplinary Delphi Expert Consensus.

Journal of clinical medicine·2025
Same author

Routine HbA1c monitoring and cardiovascular outcomes in diabetes: Evidence from a large Spanish cohort.

Primary care diabetes·2025
Same author

Identifying Dimensions and Items for a Questionnaire to Assess Medication Adherence in Men and Women with Ischemic Heart Disease: Insights from the GENADHECAR Study.

Patient preference and adherence·2025
Same author

Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study.

Endocrinologia, diabetes y nutricion·2025
Same author

[The Spanish National Commission for the Speciality of Family and Community Medicine 2014-2024: A memory of a challenge].

Atencion primaria·2025

Related Experiment Video

Updated: Nov 23, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K

[Cardiovascular preventive recommendations. PAPPS 2020 update].

Domingo Orozco-Beltrán1, Carlos Brotons Cuixart2, José Juan Alemán Sánchez3

  • 1Unidad de Investigación CS Cabo Huertas, Departamento San Juan de Alicante, Departamento de Medicina Clínica. Universidad Miguel Hernández, España.

Atencion Primaria
|January 3, 2021
PubMed
Summary
This summary is machine-generated.

This study outlines the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) recommendations for preventing cardiovascular diseases (CVD). It covers risk factors, CV risk assessment, and management strategies for hypertension, dyslipidemia, and diabetes.

Keywords:
Atencion primariaCardiovascular diseasesDiabetes mellitusEnfermedades cardiovascularesFamily medicineMedicina de familiaPreventive activitiesPrimary care

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.2K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.7K

Related Experiment Videos

Last Updated: Nov 23, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.2K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.7K

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Cardiovascular diseases (CVD) remain a leading cause of morbidity and mortality in Spain.
  • Identifying and managing key risk factors is crucial for effective CVD prevention.
  • Existing guidelines require updates to reflect current epidemiological data and best practices.

Purpose of the Study:

  • To present the updated recommendations from the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for cardiovascular disease (CVD) prevention.
  • To provide guidance on epidemiological trends, risk assessment, and management of major CVD risk factors.
  • To offer evidence-based recommendations for antiplatelet therapy and atrial fibrillation screening.

Main Methods:

  • Comprehensive review of epidemiological data on CVD in Spain.
  • Development and presentation of updated Cardiovascular (CV) risk tables.
  • Synthesis of diagnostic criteria, therapeutic objectives, and management strategies for arterial hypertension, dyslipidemia, and diabetes mellitus.
  • Inclusion of quality assessment and strength of recommendation indicators.

Main Results:

  • Detailed epidemiological review of CVD morbidity and mortality in Spain.
  • Updated CV risk tables for calculating cardiovascular risk.
  • Specific recommendations for lifestyle modifications and pharmacological treatments for major risk factors.
  • Guidelines for antiplatelet therapy and atrial fibrillation screening.

Conclusions:

  • The PAPPS recommendations provide a comprehensive framework for CVD prevention in primary care.
  • Effective management of arterial hypertension, dyslipidemia, and diabetes mellitus is essential.
  • Regular screening for atrial fibrillation and appropriate use of antiplatelet therapy can reduce CVD events.